Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
United Therapeutic
(NQ:
UTHR
)
275.00
-1.40 (-0.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
505,301
Open
276.09
Bid (Size)
274.80 (10)
Ask (Size)
275.16 (2)
Prev. Close
276.40
Today's Range
274.73 - 280.30
52wk Range
208.62 - 280.30
Shares Outstanding
44,891,523
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Halozyme Therapeutics Scores RS Rating Jump To 91
June 07, 2024
On Friday, Halozyme Therapeutics stock earned an upgrade to its Relative Strength (RS) Rating, from 80 to 91.
Via
Investor's Business Daily
For those who appreciate value investing, NASDAQ:UTHR is a compelling option with its solid fundamentals.
June 05, 2024
Investors should take notice ofUNITED THERAPEUTICS CORP (NASDAQ:UTHR)—it offers a great deal for the fundamentals it presents.
Via
Chartmill
Performance
YTD
+20.96%
+20.96%
1 Month
+3.36%
+3.36%
3 Month
+10.22%
+10.22%
6 Month
+12.31%
+12.31%
1 Year
+19.78%
+19.78%
More News
Read More
United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
United Therapeutics Corporation
Via
Business Wire
The 3 Most Undervalued Healthcare Stocks to Buy in June 2024
June 04, 2024
Via
InvestorPlace
Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics
June 03, 2024
Via
Investor's Business Daily
Topics
Intellectual Property
Exposures
Intellectual Property
Expert Ratings For United Therapeutics
May 21, 2024
Via
Benzinga
The Latest Analyst Ratings For United Therapeutics
May 02, 2024
Via
Benzinga
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
May 20, 2024
Via
InvestorPlace
Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
May 16, 2024
Via
Investor's Business Daily
NASDAQ:UTHR is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
May 15, 2024
Via
Chartmill
Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating
May 14, 2024
Via
Investor's Business Daily
3 Biotech Stocks to Double Your Money in the Next 24 Months
May 06, 2024
Via
InvestorPlace
Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity
May 01, 2024
Via
Benzinga
UTHR Stock Earnings: United Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 01, 2024
Via
InvestorPlace
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
May 01, 2024
Via
Benzinga
United Therapeutics Corporation Reports First Quarter 2024 Financial Results
May 01, 2024
From
United Therapeutics Corporation
Via
Business Wire
CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
April 26, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024
April 24, 2024
From
United Therapeutics Corporation
Via
Business Wire
NASDAQ:UTHR stands out as a stock that provides good value for the fundamentals it showcases.
April 24, 2024
Via
Chartmill
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
April 16, 2024
From
United Therapeutics Corporation
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 26, 2024
Via
Benzinga
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
March 26, 2024
From
United Therapeutics Corporation
Via
Business Wire
The Bargain Hunter’s Portfolio: 7 Smart Stock Buys for the Shrewd Investor
March 25, 2024
Via
InvestorPlace
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
March 25, 2024
From
United Therapeutics Corporation
Via
Business Wire
The 3 Most Undervalued Nasdaq Stocks to Buy in March 2024
March 13, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.